Oracle Corporation

Given the prevalence of behavioral health issues that often accompany chronic diseases, pairing a pharmacotherapy with a digital therapeutic aimed at driving behavioral change would at first blush see

FDA is about to get more money and new technology to upgrade its drug safety systems. One new technique likely to emerge in a big way is "data mining"—automated safety signal detection. The question i

In the post- Vioxx era of increased scrutiny into clinical data, spiralling trial costs and a growing mistrust of drug firms' motives, the advantages of electronic diaries for use in clinical trials

Drug firms need to conduct more, bigger, and better-monitored trials. They also need to cut costs. Electronic data capture presents a possible, but far from straightforward, solution. By Melanie Senio